PhThisis - the name being from the Greek meaning tuberculosis - was acquired by Micribiologics, St Cloud MN in October 2013. Formerly known as IDX Labs, Phthisis Diagnostics is a molecular diagnostics company focused on fast, cost-effective diagnosis and treatment of infectious diseases. The firm is focused to development of better tests to detect cryptic infections in an environment of overantibiosis. The firm's molecular diagnostics are more reliable and easier to use than existing technologies and present significant advantages to labs with superior accuracy, ease-of-use, and enhanced margins. Phthisis Diagnostics contracts with major diagnostic partners in the USA and Europe to work towards this goal. Specialties include fecal, sterile site, and fungal molecular diagnostics
